Tyra Biosciences, Inc. TYRA
20.97 USD 0.00 (+0.00%)
At closeNov 12, 2026, 9:00 AM EST
20.79 -0.18 -0.86%
Pre-market · Nov 12, 9:00 AM ET
20.72 Day range 21.37
14.67 52-week range 40.65
- YTD
- -20.24%
- 1 year
- +38.60%
News
benzinga.com Nvidia To $200? Here Are 10 Top Analyst Forecasts For Wednesday Analysts cut targets for AMBQ, TYRA, NVDA, HUBB and CAN; raised CARL and RIOT targets, while downgrading NVDA and RIOT.
benzinga.com Wedbush Maintains Outperform on Tyra Biosciences, Raises Price Target to $57 Wedbush analyst Robert Driscoll maintains Tyra Biosciences (NASDAQ:TYRA) with a Outperform and raises the price target from $53 to $57.
benzinga.com HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $27 HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Tyra Biosciences (NASDAQ:TYRA) with a Buy and lowers the price target from $29 to $27.
benzinga.com Tyra Biosciences Q3 EPS $(0.74) Misses $(0.69) Estimate Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of $(0.69) by 7.25 percent. This is a 48 percent decrease over losses of…
prnewswire.com Tyra Biosciences Reports Third Quarter 2026 Financial Results and Recent Highlights Reported initial Phase 2 SURF302 results for oral dabogratinib in FGFR3-altered low-grade IR NMIBC patients Completed $400 million financing, providing additional capital to advance dabogratinib's…
prnewswire.com Tyra Biosciences to Participate in Upcoming Investor Conferences CARLSBAD, Calif., Nov. 5, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target…
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Biohaven (NYSE:BHVN) shares increased by 39.3% to $16.37 during Thursday's pre-market session. The company's market cap stands at $1.7 billion. Vogenx (NASDAQ:VOGX) stock rose 22.05% to…
benzinga.com Oppenheimer Reiterates Outperform on Tyra Biosciences, Lowers Price Target to $40 Oppenheimer analyst Mazahir Alimohamed reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and lowers the price target from $50 to $40.- benzinga.com HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $29 HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Tyra Biosciences (NASDAQ:TYRA) with a Buy and lowers the price target from $30 to $29.
benzinga.com Stock Market Today: S&P 500, Dow and Nasdaq Futures Fall as Brent Hovers Near $107 and FOMC Commences Two-Day Meeting— MSTR, CRWD, BMM in Focus (UPDATED) U.S. stock futures declined on Tuesday, as the Dow Jones, S&P 500 and Nasdaq 100 indices fell, following Monday's lower close.
benzinga.com Crude Oil Jumps 3%; Corning Shares Move Lower U.S. stocks fell Monday as tech slid; Nvidia may invest $10B in Anthropic’s IPO. Oil rose 3%, while gold, silver and copper declined.
benzinga.com Elmet Group, Rum Group, Tyra Biosciences And Other Big Stocks Moving Higher On Monday Nasdaq fell 1%, while Elmet surged 50.6% on $450M DoD funding plans; Rum, SailPoint, Tyra and cybersecurity stocks also rallied.- benzinga.com Tyra Biosciences Prices Underwritten Offering Of 9,079,000 Shares And Warrants At $22.03 Per Unit Underwritten offering of 9,079,000 shares of its common stock at a price of $22.03 per share and, in lieu of shares of common stock to certain investors, pre-funded warrants to purchase 9,078,529…
- benzinga.com Tyra Biosciences Files Prospectus To Sell Mixed Securities Shelf Of Undisclosed Amount Common StockPreferred StockDebt SecuritiesWarrantsUnitsWe may offer and sell the securities identified above from time to time in one or more offerings. This prospectus provides you with a general…
benzinga.com Wedbush Reiterates Outperform on Tyra Biosciences, Maintains $53 Price Target Wedbush analyst Robert Driscoll reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and maintains $53 price target.
benzinga.com Apple To $370? Here Are 10 Top Analyst Forecasts For Thursday Analysts cut targets for AAPL, CHWY, COO, TYRA and CNM; raised DLR, DPZ, SIG, while ratings stayed unchanged.- benzinga.com HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $30 HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Tyra Biosciences (NASDAQ:TYRA) with a Buy and lowers the price target from $45 to $30.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Opus Genetics (NASDAQ:IRD) shares increased by 31.7% to $5.71 during Wednesday's regular session. The company's market cap stands at $361.0 million. bioAffinity Technologies (NASDAQ:BIAF)…
benzinga.com Why Is Tyra Biosciences Stock Sinking Wednesday? Tyra Biosciences stock fell sharply as initial dabogratinib Phase 2 data showed a 57% complete response rate at 60 mg.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Modular Medical (NASDAQ:MODD) shares increased by 11.3% to $3.14 during Wednesday's pre-market session. The market value of their outstanding shares is at $22.9 million. InnovAge Holding…- benzinga.com HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $45 Price Target HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Tyra Biosciences (NASDAQ:TYRA) with a Buy and maintains $45 price target.
benzinga.com Tyra Biosciences To Discuss Initial Clinical Results From SURF302 Phase 2 Study Evaluating Oral Dabogratinib For IR NMIBC In Conference Call And Webcast On September 9 Tyra Biosciences, Inc. (NASDAQ:TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor…
benzinga.com Tyra Biosciences Q2 EPS $(0.69) Misses $(0.65) Estimate Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.65) by 6.15 percent. This is a 46.81 percent decrease over losses of…
benzinga.com TD Synnex To Rally More Than 8%? Here Are 10 Top Analyst Forecasts For Friday Analysts change outlook on top Wall Street names. SNX, ORCL, EDU, ENS, SHOO, RH, have price target changes and ratings upgrades/downgrades.
benzinga.com Intel To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Thursday Top Wall Street analysts changed outlook on top names. See full list of rating changes on analyst ratings page: CHEF, NAVN, INTC, HOOD, GPCR, OTLK, ORCL.
benzinga.com Micron Technology To $900? Here Are 10 Top Analyst Forecasts For Wednesday Wall Street analysts change outlook on top names, including upgrades/downgrades. Check our analyst ratings page for complete view.- benzinga.com B of A Securities Maintains Buy on Tyra Biosciences, Raises Price Target to $42 B of A Securities analyst Geoff Meacham maintains Tyra Biosciences (NASDAQ:TYRA) with a Buy and raises the price target from $37 to $42.
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com This Hanover Insurance Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday Wall Street analysts changed ratings on top names. Check our analyst ratings page for full updates. THG, BFRI covered.
benzinga.com This Stubhub Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday Top Wall Street analysts upgraded STUB, PGNY, AMT, and BAP stocks and raised their price targets. See what other analysts think of these stocks.
benzinga.com This Interface Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday Wall Street analysts changed outlook on top names. See analyst ratings page for all changes. Analysts have mixed views on OKLO, XE, MIRM, TILE, and TYRA.- benzinga.com Wolfe Research Initiates Coverage On Tyra Biosciences with Peer Perform Rating Wolfe Research analyst Kalpit Patel initiates coverage on Tyra Biosciences (NASDAQ:TYRA) with a Peer Perform rating.
- benzinga.com HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $45 Price Target HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Tyra Biosciences (NASDAQ:TYRA) with a Buy and maintains $45 price target.
- benzinga.com Tyra Biosciences Q1 EPS $(0.64) Misses $(0.59) Estimate Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.59) by 8.47 percent. This is a 36.17 percent decrease over losses of…
benzinga.com This Tyra Biosciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday 'Top Wall Street analysts changed outlook on top names. See all rating changes incl. upgrades, downgrades & initiations. TYRA rated Buy by analysts.'
benzinga.com Accenture To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Tuesday 
benzinga.com Northrop Grumman Posts Downbeat Results, Joins Halliburton And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session 
benzinga.com Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket 
benzinga.com Why WaFd Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket 
benzinga.com Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket 
benzinga.com Neumora Therapeutics, XPeng And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - benzinga.com Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarter financial results.
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session - benzinga.com Clorox Posts Upbeat Earnings, Joins Cigna, Deckers Outdoor And Other Big Stocks Moving Higher On Friday U.S. stocks traded mixed, with the Dow Jones falling over 100 points on Friday.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023
- benzinga.com Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per…
- benzinga.com Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.
- benzinga.com Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target.
benzinga.com Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday Gainers- benzinga.com Why Everbridge Jumped Over 17%; Here Are 90 Biggest Movers From Friday Gainers Micro Focus International plc (NYSE: MFGP) shares surged 92% to close at $6.01 on Friday after the company reached an agreement with OpenText to be acquired for $6 billion.